-
公开(公告)号:US20230383257A1
公开(公告)日:2023-11-30
申请号:US18248193
申请日:2021-10-15
发明人: Elizabeth SHPALL , Katy REZVANI , Bijender KUMAR , Mayela MENDT , Vahid AFSHAR-KHARGHAN , Rafet BASAR
CPC分类号: C12N5/0644 , A61K35/19 , C12N2506/1369 , C12N2502/11 , C12N2501/727 , C12N2501/125 , C12N2501/145 , C12N2501/2306 , C12N2501/724
摘要: Embodiments of the disclosure include systems, methods, and compositions for producing megakaryocytes and platelets for recipient individuals in need thereof. The megakaryocytes and platelets are produced following co-culture of MSCs and CD34+ cells in media comprising stem cell factor, thrombopoietin, and IL-6, and wherein at least the CD34+ cells have a knock-in of HLA-E at the beta-2-microglobulin genomic locus, in specific embodiments. In some cases, ROCK inhibitors are utilized.